Takeda Pharmaceutical (OTCMKTS:TKPYY) Reaches New 12-Month Low at $14.03

Takeda Pharmaceutical Company Limited (OTCMKTS:TKPYY)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $14.03 and last traded at $14.10, with a volume of 4562624 shares trading hands. The stock had previously closed at $14.22.

The firm has a market capitalization of $22.12 billion, a price-to-earnings ratio of 12.11 and a beta of 0.42. The business’s 50-day moving average is $16.48 and its two-hundred day moving average is $16.84. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.12 and a current ratio of 1.42.

About Takeda Pharmaceutical (OTCMKTS:TKPYY)

Takeda Pharmaceutical Co, Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

Featured Story: What is an Initial Public Offering (IPO)?

Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.